This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UnitedHealthcare, MultiPlan say anesthesiologists' US antitrust claims make no sense

( October 10, 2022, 22:31 GMT | Official Statement) -- MLex Summary: UnitedHealthcare Insurance and MultiPlan moved to dismiss US antitrust claims filed by anesthesiologists, arguing that they make no sense. They said that Long Island Anesthesiologists alleges that reimbursement rates under federal law are lower than prevailing rates under a New York statute but fails to explain how United or MultiPlan caused that alleged harm. “The New York Department of Civil Service—not United or MultiPlan—sponsors and funds reimbursements under the Empire Plan. DCS (not United or MultiPlan) decided to follow federal law. If LIA is upset about the Empire Plan’s decision, it should take that up with DCS,” they said. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections